Jim Shaffer
Corporate Officer/Principal bei PRECIGEN, INC.
Profil
Jim Shaffer is currently the Senior Vice President & Head of Commercial Operations at Precigen, Inc. Previously, he held positions as President, CEO & Director at Aer Therapeutics, Inc., Vice President of Sales & Marketing at New River Pharmaceuticals, Inc., Chief Commercial Officer at Halozyme Therapeutics, Inc., Chief Business Officer at Eiger BioPharmaceuticals, Inc., and Chief Commercial Officer at Clinical Data, Inc. Mr. Shaffer completed his undergraduate degree at The Ohio State University and earned an MBA from Fisher College of Business.
Aktive Positionen von Jim Shaffer
| Unternehmen | Position | Beginn |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jim Shaffer
| Unternehmen | Position | Ende |
|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Sales & Marketing | - |
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Corporate Officer/Principal | - |
| EIGER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aer Therapeutics, Inc.
 Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aer Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Raleigh, NC. The company's mission is to advance the treatment paradigm for mucus mediated lung diseases. The company is dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases, with their initial focus being on chronic obstructive pulmonary disease (COPD) and other muco-obstructive lung diseases to follow, including asthma, cystic fibrosis, and primary ciliary. The company was founded by John Fahy, and the CEO is Jim Shaffer. | Chief Executive Officer | - |
Ausbildung von Jim Shaffer
| The Ohio State University | Undergraduate Degree |
| Fisher College of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Health Technology |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
Aer Therapeutics, Inc.
Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aer Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Raleigh, NC. The company's mission is to advance the treatment paradigm for mucus mediated lung diseases. The company is dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases, with their initial focus being on chronic obstructive pulmonary disease (COPD) and other muco-obstructive lung diseases to follow, including asthma, cystic fibrosis, and primary ciliary. The company was founded by John Fahy, and the CEO is Jim Shaffer. | Health Technology |
